EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy

Yao Shen, Nairui Fan, Shu-Xia Ma, Xin Cheng, Xuesong Yang, Guang Wang

MedComm · 2025-05 · 6 (5)

DOI: 10.1002/mco2.70168 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 18.04.2025. Verfasst von Yao Shen und 5 weiteren Autor:innen. Beteiligte Einrichtung: International Joint Laboratory for Embryonic Development & Prenatal Medicine Division of Histology and Embryology School of Medicine Jinan University…. Die Arbeit wurde bisher 349-mal zitiert (Crossref) und nennt 346 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysbiosis refers to the disruption of the gut microbiota balance and is the pathological basis of various diseases. The main pathogenic mechanisms include impaired intestinal mucosal barrier function, inflammation activation, immune dysregulation, and metabolic abnormalities. These mechanisms involve dysfunctions in the gut–brain axis, gut–liver axis, and others to cause broader effects. Although the association between diseases caused by dysbiosis has been extensively studied, many questions remain regarding the specific pathogenic mechanisms and treatment strategies. This review begins by examining the causes of gut microbiota dysbiosis and summarizes the potential mechanisms of representative diseases caused by microbiota imbalance. It integrates clinical evidence to explore preventive and therapeutic strategies targeting gut microbiota dysregulation, emphasizing the importance of understanding gut microbiota dysbiosis. Finally, we summarized the development of artificial intelligence (AI) in the gut microbiota research and suggested that it will play a critical role in future studies on gut dysbiosis. The research combining multiomics technologies and AI will further uncover the complex mechanisms of gut microbiota dysbiosis. It will drive the development of personalized treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

diseasedysbiosisgut microbiotaprecision medicine

Autor:innen und Institutionen

  • International Joint Laboratory for Embryonic Development & Prenatal Medicine Division of Histology and Embryology School of Medicine Jinan University Guangzhou China.
  • Key Laboratory for Regenerative Medicine of the Ministry of Education Jinan University Guangzhou China.
  • Basic Medical College of Jiamusi University Heilongjiang China.
  • International School Guangzhou Huali College, Zengcheng Guangzhou China.
  • Guangdong-Hong Kong Metabolism & Reproduction Joint Laboratory Guangdong Second Provincial General Hospital School of Medicine Jinan University Guangzhou China.

Förderung

  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Shen, Y., Fan, N., Ma, S. X., Cheng, X., Yang, X., & Wang, G. (2025). Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy. MedComm, 6(5). https://doi.org/10.1002/mco2.70168

Vancouver

Shen Y, Fan N, Ma SX, Cheng X, Yang X, Wang G. Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy. MedComm. 2025;6(5). doi:10.1002/mco2.70168

BibTeX
@article{Shen2025,
  author = {Shen, Yao and Fan, Nairui and Ma, Shu-Xia and Cheng, Xin and Yang, Xuesong and Wang, Guang},
  title = {Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy},
  journal = {MedComm},
  year = {2025},
  volume = {6},
  number = {5},
  doi = {10.1002/mco2.70168}
}
Kostenlos starten →